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Here we describe the results of some experimental laboratory studies aimed at verifying the efficacy of
high dilutions of substances and of homeopathic medicines in models of inflammation and immunity.
Studies carried out on basophils, lymphocytes, granulocytes and fibroblasts are reviewed. This approach
may help to test under controlled conditions the main principles of homeopathy such as ‘similarity’ of
drug action at the cellular level and the effects of dilution/dynamization on the drug activity. The current
situation is that few and rather small groups are working on laboratory models for homeopathy. Regard-
ing the interpretation of data in view of the simile principle, we observe that there are different levels of
similarity and that the laboratory data give support to this principle, but have not yet yielded the ultimate
answer to the action mechanism of homeopathy. Evidence of the biological activity in vitro of highly
diluted-dynamized solutions is slowly accumulating, with some conflicting reports. It is our hope that
this review of literature unknown to most people will give an original and useful insight into the
‘state-of-the-art’ of homeopathy, without final conclusions ‘for’ or ‘against’ this modality. This kind
of uncertainty may be difficult to accept, but is conceivably the most open-minded position now.
Keywords: in vitro test – laboratory models – homeopathy – high-dilution – immune system –
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Introduction
The reliability of homeopathic principles (similia, globality of
cure and use of high dilutions of ‘natural’ medicines) and their
possible scientific bases can be assessed using various theoret-
ical and experimental approaches. In this contribution we ana-
lyze the experimental evidence on cells and laboratory
systems. Our aim is not to justify the clinical use of homeo-
pathic medicines but to present evidence showing that sub-
stances prepared according to the homeopathic method have
some effects on the immune system and inflammation. This
may be the first step for a re-evaluation of homeopathy as a
worthwhile field for basic and clinical investigations.
We are perfectly aware that the classical experimental
approach to immunology based on the laboratory, animal and
clinical experiments, typical of academic medicine and the
current international scientific literature, can help us to under-
stand only some of the aspects of homeopathy. Even bearing
in mind the limitations of this ‘reductionistic’ approach, we
still believe that it can build some bridgeheads toward the con-
struction of a united medicine. This is mainly because we are
not so much seeking to ‘demonstrate’ a single mechanism of
action, but to understand general ‘rules’ of physiology, patho-
logy and pharmacology that are the same in different fields of
biology and pharmacology, and that can also be applied to
homeopathy.
Immunoallergology represents a bridge between homeo-
pathy and modern medicine insofar as it is a field in which it
is easier to apply concepts such as the effect of substances
administered on the basis of the logic of the ‘similarity’ and
the great sensitivity of living systems to modulations induced
by ultra-low doses or high dilutions of natural or endogenous
substances (1).
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Below, we describe the principal results of experimental
studies aimed at verifying the efficacy of homeopathic medi-
cines or, more limitedly, at verifying the main principles of
homeopathy (e.g. dilution, similarity) in models of inflamma-
tion and immunity. We begin with in vitro studies of inflam-
matory cells (basophils, neutrophils, lymphocytes,
macrophages and fibroblasts), and, in a subsequent paper, we
shall examine animal studies before describing clinical trials
in humans. Many of these experiments and observations are
normally ignored by the modern biomedical literature.
We have performed experiments in our laboratory and have
monitored the literature on the subject of this paper for the
past 15 years. Here the best of our knowledge of all
experimental work published is reported, irrespective of
results (e.g. positive or negative results, in favor or against to
homeopathy). All literature available in Medline, conference
proceedings and books was searched. Due to the relative scar-
city of literature in this field and the heterogeneity of experi-
ments, we have not performed pooling and meta-analysis of
data. Where indicated, a few comments on reliability of find-
ings and on problems of replication of specific studies have
been provided.
Basophils/Mast Cells
One of the laboratory models in which the phenomena of
similarity and of high-dilution effects have been most widely
investigated is the regulation of basophils and mast cells,
which are fundamental cells in acute inflammation. In fact,
one of the first biological events in acute inflammation—and
immediate hypersensitivity in the case of pathology—is
activation of basophils/mast cells triggered by their binding
to IgE antibodies bound to high-affinity receptors as a result
of sensitization. Since this is the most investigated model of
high-dilution effects, some technical details may help under-
standing the results.
Biology of Basophil Activation
In these cells, internal activation is driven not only by specific
foreign substances such as allergens but also by the binding of
antibodies (anti-IgE) against heavy chains of IgE, which are
the receptors of antigens in these cells. The cell activation
involves changes in membrane ion fluxes (particularly calcium
ions), changes in cell membrane electrical polarity, and other
mechanisms that eventually lead to exocytosis and the release
of mediators (Fig. 1). It is known that one of the main mediat-
ors is histamine, which is produced by the decarboxylation of
histidine, stored in granules of basophils and mast cells, and
released a few seconds after activation. Histamine in tissues
exert vasodilating and permeabilizing actions (and therefore
causes the formation of wheals and edema).
At the end of the 1980s, when the first published studies
aroused considerable international controversy (2,3), there
were two ways of evaluating the reactivity of basophils: the
histamine release test, which measures histamine released by
activated basophils into the extracellular environment, and
the basophil ‘degranulation’ test, which analyzes changes in
coloring of granules in presence of stains such as toluidine
blue or alcian blue (metachromasia). In practice, a microscope
count is made of the unstained (‘degranulated’) cells in rela-
tion to the total number of basophils (4) (Fig. 1). This is erro-
neously called a ‘degranulation’ test because metachromasia
may occur at activator doses that are much lower than the
threshold required to trigger degranulation (5). Metachromasia
probably reflects biochemical changes (the exchange of
cations) that alter the interaction of basic dyes with pro-
teoglycans of granule. Although it is easy to establish a cor-
relation between the two methods using strong stimuli, this is
not true when weak stimuli or very low agonist doses are
used: the activation of basophils without true degranulation
(i.e. without histamine release) has been observed under
many circumstances (6).
Early Studies
Experimental studies of this cell type have been carried out by
two groups of French researchers (Sainte-Laudy with Belon
and Poitevin with Aubin) using homeopathic dilutions of
Apis mellifica and Lung histaminum. The choice of these com-
pounds was probably due on their frequent use in the treatment
of allergic syndromes (7) and partially on the known ability of
some of their molecular components (mellitin and histamine,
respectively) to activate basophils or to have regulatory feed-
back effects on them. The studies were based on the hypothesis
Figure 1. Normal activation of basophil degranulation caused by anti IgE
antibodies. This activation is not only driven by specific allergens, but also
by the binding of antibodies against IgE heavy chains (anti-IgE) and involves
changes in membrane ion fluxes (particularly calcium ions), changes in cell
membrane electrical polarity, and other mechanisms that eventually lead to
exocytosis and the release of mediators. Cell activation is evaluated by optical
microscopy as a loss of staining properties. To be precise, loss of staining prop-
erties is not exactly the same biological phenomenon as cell degranulation, but
indicates a change of the granule membrane permeability. Another typical
response to activation is the increased expression of CD63 proteins, which
are translocated from internal pools to the cell surface. Insert: electron micro-
scopy of a mast cell.
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that, even in homeopathic dilutions, these substances can regu-
late basophils activated by ponderal doses of an active agent.
The first publications describing the effect of these homeo-
pathic dilutions on basophils (8,9) reported that the in vitro
degranulation induced by various allergens (domestic dust,
house mites) was stimulated (þ20%) by low dilutions (5c)
(centesimal and decimal homeopathic dilutions, or ‘potencies’
in homeopathic terms, are designed as ‘c’ and ‘x’, respect-
ively.) of bee venom (Apis mellifica), whereas higher dilutions
(9c and 15c) had an opposite effect (>50% inhibition). These
effects were obtained by including the medicines in the
incubation mixture and were statistically significant. The
inhibition by Histaminum and Apis is particularly interesting
because when released at normal doses into a tissue both
histamine and bee venom have pro-inflammatory powers and
irritant properties. This experiment therefore illustrates
application of the principle of similarity in an experimental
model: a substance known to stimulate inflammation at
conventional doses can, at different doses, inhibit cells
responsible for many of the phenomena of the inflammatory
process.
Another group has unsuccessfully tried to repeat the same
experiments (10), but the authors of the first study report that
the same protocol was used by a third and independent labor-
atory upon the request of the French Academy of Medicine
and that, in this case, all three dilutions of Apis mellifica (5c,
9c, 15c) had a statistically significant inhibitory effect (11).
In order to explore the question further, and with the support
of the team of Benveniste (which at that time was still working
at INSERM U200 in Paris), Poitevin carried out another series
of ‘blind’ experiments using 1c–15c dilutions of Apis mellifica
and Lung histaminum on basophils activated by anti-IgE
antibodies (12) (Fig. 2). Lung histaminum is an extract of
lung from laboratory animals where anaphylactic reactions
are experimentally induced, so it presumably contains, at least
in the starting material (mother tincture), histamine as a medi-
ator. The dilution-effect curves of these products showed an
alternation of inhibition, inactivity and stimulation with a
unusual and complex trend: Apis significantly inhibited
basophil activation at the dilutions of 8c, 9c and 10c when
the basophils were activated with high and low anti-IgE
doses, and caused significant inhibition also at the dilutions
of 5c, 7c, 13c and 20c when the basophils were activated
with low anti-IgE doses. With Lung histaminum, significant
inhibitions were observed at dilutions of about 5c and about
15c (from 12c to 18c). In the case of basophils activated using
small anti-IgE doses, Apis 10c and Lung histaminum 18c
caused 100% inhibition.
The Benveniste Affair
The famous multicenter study, led by J. Benveniste and
involving four other laboratories, reported that human baso-
phils undergo ‘degranulation’ (metachromasia) not only at
usual anti-IgE antibody doses (103 mg/ml) but also at
extremely high dilutions (1060 or 10120 times lower than the
concentrations usually leading to a molecular interaction) (2)
(Fig. 3). The dose–response curves at decreasing doses first
showed the disappearance of activity and then its re-
appearance followed by various peaks of alternating activity
and inactivity up to extremely high dilutions corresponding
to practically zero antibody concentrations. This type of a
dose–response curve is also called ‘pseudo-sinusoidal’. In
addition to anti-IgE antibodies, significant results were also
obtained using high dilutions of substances such as calcium
ionophores and phospholipase A2, known to have stimulatory
effect at ponderal doses. The specificity of action was proved
by the lack of effect of other highly diluted substances such as
anti-IgG antibodies (basophils are only activated by anti-IgE
Figure 2. Inhibition of basophil degranulation by homeopathic dilutions of
Apis mellifica and Lung histamine (8,11,12).
Figure 3. The scheme of the study reporting that basophils undergo ‘degranu-
lation’ (metachromasia) not only at usual anti-IgE antibody doses (103 mg/
ml) but also at extremely high dilutions (1060 or 10120 times lower than the con-
centrations usually leading to a molecular interaction) (2). The dose–response
curves of Anti-IgE (see insert) at increasing dilutions first showed the disap-
pearance of activity and then its re-appearance followed by various peaks of
alternating activity and inactivity up to extremely high dilutions.
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antibodies) and phospholipase C, which have a different bio-
chemical specificity on membranes (2). It is observed interest-
ing to note that the high-dilution effect was observed only
when the serial dilution was followed by strong succussion
(‘dynamization’ in homeopathic terminology) of the solutions.
The work of Benveniste’s group was published in the author-
itative scientific journal Nature and had considerable reson-
ance as the presumed demonstration of the ‘memory of
water’, but it was heavily criticized on theoretical grounds
(the ‘incredibility’ of the data) and because of the difficulty
in reproducing the results, as well as for methodological
weaknesses (a sort of inspection of Benveniste’s laboratory
organized by Nature) (3,13,14).
The group subsequently repeated tests using more reliable
methods and more complete evaluations made by expert stat-
isticians, and confirmed many times the existence of an effect
at high dilutions, although it was not so marked as that
described in the first paper (15–18). These further experiments
are not known by the general public, and possibly because they
were published in less renowned journals or in conference pro-
ceedings they have not been welcomed by the scientific com-
munity.
A Dutch group reported its inability to reproduce the effect
of high IgE dilutions (19). This study failed to demonstrate
any action of high anti-IgE antibody dilutions on mast cells,
and the authors (one of whom had learned the technique in
Benveniste’s laboratory) concluded that it was a difficult to
reproduce model. Similar negative results have also been
reported by another group (20). However, according to
Benveniste, these studies apparently refuting his results
were marred by a number of methodological and statistical
errors (21).
As pointed out by Vecchi (22), in data of Table 2 from Hirst
et al. (20), the probability that the successive high dilution
behaves as the control solution is 0.0027 (Fischer P-value).
This represents the probability of obtaining such experimental
data by chance, under the assumption that there will be no dif-
ference between successive high dilutions and control treat-
ments. In other words, the experimental data confirm within
a 99.7% level of confidence that there is a difference between
successive high dilutions and control treatments. The authors
appear to recognize that their data are incompatible with the
null hypothesis, i.e. with the assumption that there is no differ-
ence between potentized solutions and placebo (p. 527, right
column): ‘According to conventional scientific theory, there
should be no differences within a session between the control
treatment and the eight high-dilution treatments. . . . This is
not the case . . .’, but they attribute the effect to unknown
causes. It is difficult to determine the difference between the
‘unknown variation source’ in Hirst et al. and the perplexing
intermittency that appears in Benveniste’s original paper and
that was construed there in terms of ‘dilution waves’. What
appears to be happening is largely consistent with the findings
of Davenas et al. (2): successive anti-IgE strongly enhances
the variation in basophil counts, while affecting the mean
counts only moderately. The high-dilution story of basophils
is therefore still open at the experimental level, as is demon-
strated by other authors working on this type of research
(23,24) and by other results reported below.
Inhibition by Pure Histamine
The group of Belon/Sainte-Laudy obtained the inhibition of
basophil ‘degranulation’ (according to metachromasia) by
using high dilutions of pure histamine (Fig. 4). If the initial
concentration is known, the use of pure substances as the start-
ing material makes it possible to determine the theoretical
molar concentrations in the subsequent dilutions, which, in
this case, are expressed as negative powers of 10. A first series
of experiments led to two inhibitory peaks at dilutions with
theoretical histamine concentrations of between 1010 and
1017 M and between 1030 and 1038 M (25). All of the
experiments were carried out under blind conditions in the
sense that the researcher did not know with which dilution
s/he was working. A control experiment showed that dilutions
of histidine (the carboxylated precursor of histamine) were
inefficacious, thus confirming specificity of the molecular
information and reducing the likelihood of laboratory artifacts.
The same group has reported further data confirming
that high dilutions of histamine (pure histamine chloride) sig-
nificantly inhibit the degranulation of basophils (sensitized
by IgE antibodies against dermatophagoid) induced in vitro
by dermatophagoid extracts (26). Using a series of 16 pro-
gressive one-hundredth dilutions (from 5c to 20c), the authors
observed inhibitory activity at dilutions of about 7c and 18c.
The addition of pharmacological doses of cimetidine (an ant-
agonist of histamine H2 receptors) abolished effects of all of
active dilutions. Adding of the histaminase enzyme (which
destroys histamine) inhibited the effect of ponderal doses (6c
and 7c) but not that of high dilutions (18c), thus indicating
that the latter was not due to the histamine molecule but to
other mechanisms. The authors therefore tend to believe that
the action of high dilutions involves an effect of the solvent
(water) on H2 receptors, although they do admit that it is
Figure 4. The effects of ultra-high dilutions of pure histamine on basophil
activation, assessed by optical evaluation of granule staining (25–27).
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paradoxical to think in terms of molecular biology when there
are theoretically no molecules of the effector in some of the
active dilutions tested. A further paper confirmed that the
IgE activation of human basophils is greatly and significantly
(P < 0.001) inhibited by histamine dilutions (27). In these
experiments, the ‘degranulation’ of basophils was inhibited
at theoretical histamine concentrations of 1016, 1018,
1020, 1022 and 1036 M.
New Techniques: Role of CD Markers
As the results obtained with the ‘degranulation’ test have never
been replicated using the histamine release test in vitro
(probably because of the different sensitivity of the two
methods in relation to the different stages of basophil activa-
tion), it was important to replicate them by means of the differ-
ent test of flow cytometry (28). Basophil membranes express
many proteins: adhesion molecules and high-affinity receptors
for IgE, aggregated IgG, CD26, CD33, CD40, CD45 and
CD63. The last one is particularly interesting because it is
expressed on cytoplasmic granules and on the external mem-
brane after activation, and can thus be used as a marker of
the functional status of the cell and also for ex vivo allergolo-
gical diagnoses (29). Flow cytometry has the further advantage
of being objective because it does not rely on judgment of the
observer, whereas the degranulation test requires a visual
evaluation as to whether the cells are light or dark after
staining.
This technique has been used to demonstrate that basophil
activation by anti-IgE antibodies (Fig. 5), observed as an
increased expression of CD63, is blocked by ‘conventional’
histamine doses of between 102 and 104 M, as well as by
(theoretical) ultra-low doses of 1022 and 1034 M (30). The
same authors have also demonstrated that the inhibition
induced by very high histamine dilutions (theoretical dose of
1030 to 1034 M) is abolished by cimetidine, thus confirming
the receptor specificity already reported by their previous
data (31).
Is the Phenomenon Reproducible?
Furthermore, similar results have been obtained by three of
the four laboratories involved in a multicenter collaboration
(24) and independently reproduced (32–34). Only one group
was not able to confirm the previously reported effects of
high histamine dilutions on basophil function (35). In seven
independent experiments, basophils of the same human
donor were incubated with diluted histamine (up to 1034 M)
or water controls and activated with anti-IgE antibodies. Baso-
phil activation was determined by using bi-color flow cyto-
metry. Experiments were blinded and performed with a
randomized arrangement of solutions on microtiter plates.
Histamine at the dilutions 102 M and 1022 M was associated
with a significant inhibition of basophil degranulation
(P ¼ 0.018) of 23.1 and 5.7%, respectively, if compared
with control (‘diluted’ water treated in an identical manner).
However, if all controls were pooled, only histamine 102 M
had a significant effect. The authors suggest that minor vari-
ables of the experimental set up, such as the position of
samples in different rows of the same laboratory microplate,
can lead to significant differences of results if not properly
controlled.
In conclusion, this experimental model, using the highly
sensitive basophil, has been very fruitful, and can be con-
sidered particularly consolidated and credible. These data
are summarized in Table 1. However, the research in this
field has been till now unable to give a clear-cut technical
explanation of the observed discrepancies between different
laboratories. Hopefully, in the future, use of rigorously con-
trolled experimental conditions and multicenter cooperations
will help to identify and to minimize confounding factors.
Figure 5. The effects of ultra-high dilutions of pure histamine on basophil
activation, assessed by flow-cytometric measurement of CD63 expression
(24,30–34). Data reported in the insert are from Brown and Ennis (32).
Table 1. Summary of laboratory studies on basophils/mast cells
 High dilutions (up to 10120) of Anti-IgE antibodies stimulate basophil
degranulation (2). This result was not confirmed by two independent
groups (19,20).
 Homeopathic dilutions of Apis Mellifica and Lung Histamine inhibit
basophil degranulation (8,11,12).
 High dilutions of Histamine (1020 to 1038 M) influence the activation of
human basophils measured by alcian blue staining (25–27). A multicenter
study confirmed this finding in different laboratories, using several different
techniques (24,30,32).
 Inhibition of basophil activation by high dilutions of histamine is reversed
by anti-H2 and is not observed with histidine, these results being in favor of
the specificity of this effect (31).
 An independent team confirmed the inhibitory effect of high dilutions of
histamine (1022to 1025M histamine) (33,34).
 One report (35) failed to replicate these findings: histamine consistently
inhibited basophil degranulation only when used in low dilutions.
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Lymphocytes
Studies dating back several years have tested the in vitro
effects of medium dilutions of plants used in homeopathic
medicines on lymphocytes. Two particularly interesting stud-
ies report the effect of Phytolacca on lymphocyte prolifera-
tion, measured by means of 3H-thymidine incorporation
(36,37). Phytolacca contains a glycoprotein (the mitogenic
Pokeweed) that is known to induce lymphoblastic transforma-
tion in cultured B-lymphocytes. Phytolacca has also been
empirically used in homeopathy for a long time (since before
its in vitro immunological action was discovered) in order to
treat numerous diseases involving lymphoadenopathies, such
as infectious mononucleosis and otorhinolaryngoiatric viral
disease (38). Phytolacca dilutions of 5c, 7c and 15c have no
mitogenic effect on resting lymphocytes but on lymphocytes
stimulated with ponderal doses of phytohemagglutinin they
inhibit mitosis by 2873%: one study using rabbit lympho-
cytes found that the 15c dilution had the greatest effect (36);
another study using human lymphocytes found that the max-
imum effect was achieved by the 7c dilution (37). Once again,
these experiments underline the concepts of biological tropism
(according to which an ultra-diluted solution acts on the same
target system as the undiluted substance) and ‘similarity’ as
effect inversion (according to which the diluted solution
inhibits the effects of original or a similar substance). Unfortu-
nately, this line of research has not been expanded by further
experimental studies.
In vitro studies may also help to characterize homeopathic
medicines for their active principles, which are undoubtedly
present in crude extracts (mother tinctures) and low dilutions.
Arbor vitae (Thuja occidentalis L.) is a native European tree
widely used in homeopathy and phytotherapy. A recent review
has presented the phytochemistry properties of its essential oil
(Thujone), its antiviral action and immunopharmacological
potential, such as stimulatory and co-stimulatory effects on
cytokines, antibody production, and activation of immuno-
competent cells and macrophages. The in vitro effects have
been observed using ponderal doses (low dilutions) of the plant
extract and of its active principles (39).
Hormesis and Sensitization
Wagner’s group (40) has tackled experimentally the problem
of the effect at cell level (i.e. on leukocytes) of low doses
of vegetable extracts used in homeopathy and, in addition, of
unusual changes in effect observed in dose–response curves.
Among the various studies made by this group, of particular
interest are those reporting that relatively high concentrations
(100 mg10 ng/ml) of the naphthoquinones (plumbagin,
alkannin and others) and cytostatic agents (vincristine, metho-
trexate and fluorouracil) inhibit lymphoblastic transformation
and granulocyte phagocytosis, whereas low concentrations
(10 pg10 fg/ml) have a stimulatory effect: intermediate doses
are ineffective. The authors suggested that a number of the
antitumoral effects of vegetable extracts might be explained
by this dose-related double-effect mechanism. This is an
immunological example of U-shaped dose–response curves
that have been described earlier in toxicology as the ‘Arndt-
Schultz law’ (41,42) and then theoretically developed as the
‘hormesis’ effect (43–46). This phenomenon could be a pos-
sible mechanism underlying the inversion of drug effects, or
paradoxical effects of drugs, that recalls the traditional ‘simil-
arity’ principle of homeopathy. However, hormesis can
explain only a few aspects of homeopathy (47–49).
A study of the action of successive substances on human
lymphocytes stimulated with phytohemagglutinin (PHA) was
conducted by a team in Bucharest (50). Human peripheral
blood lymphocytes from healthy controls, immunodepressed
patients presenting with chronic bacterial infections or neo-
plasias and allergic patients were stimulated in vitro with
PHA in a culture medium supplemented or not with high dilu-
tions (107, 1015 or 1030) of bee venom or phosphorus in tri-
distilled water. The most significant inhibition due to DNA
incorporation was noted in lymphocytes from allergic patients
cultivated in media supplemented with 1030 dilutions in the
presence of PHA. The cells from immunodepressed patients
showed no significant inhibition at 1030 dilution. According
to the authors, these data suggest a possible effect of high
dilutions on structures of cell membranes from sensitized
subjects. In this case, the sensitization due to pathology would
make the individual susceptible to the homeopathic dilution.
In vitro Testing of Complex Formulations
A complex homeopathic medicine (Engystol-N, composed of
Vincetoxicum at dilutions 6· to 30· and of Sulfur at dilutions
4· to 10·) stimulates cytokine(s) production by T lymphocytes
in whole blood (51). Culture media of T lymphocytes treated
with 104 and 108 dilutions of Engystol-N show an inhibiting
effect on superoxide anion generation by neutrophils. From
these data it was concluded that the drug stimulates secretion
of lymphokine(s) with an inhibiting action on superoxide
anion generation by neutrophils that prevail over the direct
stimulating effect, confirming and extending the suggested
immunomodulatory ability of the drug.
A homeopathic complex medicine (‘Canova’) is used as an
immune modulator (52). The formula is composed of 19·
Thuya occidentalis, 18· Bryonia alba, 11· Aconitum napellus,
19· Arsenicum album and 18· Lachesis muta (Viperidae)
venom, all extracted and diluted in 70% alcohol, in equal parts.
Studies of its mechanism of action have shown that it stimu-
lates the immune system by activating macrophages, but has
no genotoxic properties in vitro on lymphocytes (53).
Traumeel S, a homeopathic formulation containing
low potencies (4· to 12·) of Arnica montana and other plant
extracts and minerals (Calendula officinalis, Hamamelis
virginiana, Achillea millefolium, Atropa belladonna,
Aconitum napellum, Hepar sulfuris, Symphytum, Mercurius
solubilis, Bellis perennis, Chamomilla, Echinacea angustifo-
lia, Echinacea purpurea, Hypericum) is widely used in
humans to relieve trauma, inflammation and degenerative
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processes. However, little is known about its possible effects
on the behavior of immune cells. The effects of Traumeel
were examined in vitro on human T cells, monocytes and gut
epithelial cells (54). Traumeel inhibited the secretion of IL-
1beta, TNF-alpha and IL-8 secretion by 5070% in both rest-
ing and activated cells (P < 0.01 for all cells). Interestingly,
the effect appeared to be inversely dose-related: maximal
inhibition was seen with dilutions of 103 to 106 of the medi-
cine stock material. This finding suggests that Traumeel does
not inhibit immune cell functions by exerting a toxic effect.
Although additional studies are needed to clarify the mode of
action of this homeopathic formulation (see also the studies
on neutrophil granulocytes reported below), the in vitro results
may offer a mechanism for its anti-inflammatory effects. The
main results on lymphocytes are summarized in Table 2.
Polymorphonuclear Granulocytes
(Neutrophils)
Among studies of possible regulatory effects of homeopathic
dilutions on inflammation, mention must be made of those
involving phagocytic cells and in particular polymorphonuc-
lear leukocytes (neutrophil granulocytes). In this case, the
tested substances were those used by homeopaths in situations
of acute inflammation with a major polymorphonucleat
component.
It has been reported (55) that 5c and 9c dilutions of
Belladonna and Ferrum phosphoricum inhibit the production
of free oxygen radicals (measured as chemiluminescence, i.e.
release of light generated during metabolic reactions) by
granulocytes stimulated by opsonized zymosan. The inhibition
was highly significant and as much as 30–40%, approximately
the same as that obtained using 10 mM of dexamethasone and
0.1 mM of indomethacin. The authors pointed out that there
was a considerable difference in individual sensitivity to these
drugs, and this problem of the different sensitivity of cells
isolated from different subjects has also been highlighted by
others (56) who have investigated the effect of Belladonna,
Hepar sulfur, Pyrogenium, Silicea and Staphylococcinum on
chemotaxis and obtained conflicting results.
It has also been reported (in a preliminary communication)
that Bryonia 4c and 9c (family: Cucurbitaceae) had a stimulat-
ory effect on oxidative metabolism of polymorphonuclear
leukocytes, which may be both direct and indirect (increasing
the response to chemotactic peptides) (57).
Our Investigations of Homeopathic Medicines In Vitro
Our own group has also investigated the effects of homeo-
pathic medicines on inflammatory cells and has obtained signi-
ficant results particularly in relation to low dilutions (58–63).
We first explored the possible direct effect of homeopathic
dilutions on cell systems by evaluating their in vitro effects
on oxidative metabolism of cultured neutrophils activated by
formylated peptides (60). Results of the first series of studies,
based on analysis of multiple dilutions of a large series of com-
pounds, can be summarized as follows: (i) Manganum phos-
phoricum 6· and 8·, Magnesium phosphoricum 6· and 8·,
Sulphur 6·, Acidum citricum 3· and Acidum succinicum 3·
and 4· have highly reproducible inhibitory effects on our in
vitro assay system; ii) Acidum fumaricum and Acidum malicum
(both at a dilution of 4·) have a slightly potentiating effect
on oxidative metabolism; (iii) during the course of various
experiments, Phosphorus and Magnesium phosphoricum
often showed inhibitory effects even at very high dilutions
(>15·), but these did not always appear at the same dilutions,
thus making it difficult to analyze them statistically; however,
by pooling all of the data concerning the effects of high
phosphorus dilutions, it has been possible to identify a small
(10–15%) but statistically significant inhibition of cell
activation.
These results can be biochemically interpreted in many
ways. First of all, they demonstrate that, at medium–high
doses, the solutions have certain effects on blood cells.
Furthermore, they seem to suggest that most of the tested rem-
edies interfere with subtle cell most regulatory mechanisms
known to be based on ion exchanges, phosphorylation pro-
cesses and reduced oxidation. In normal cell most physiology,
phosphorus, sulphur, magnesium, manganese, calcium and
other elements play a major role in such mechanisms, and so
it is particularly interesting that some homeopathic medicines
can act at these levels of control.
We then carried out studies aimed at improving knowledge
of the anti-inflammatory action of Traumeel S (61,62). Results
showed a decrease in paw edema associated with the process
of healing, which was more rapid in the treated rats
(P < 0.05 after three and P < 0.01 after 5 h) than in controls
treated with saline (0.9% NaCl) solvent. The effects of
Traumeel S on two important cellular functions, namely super-
oxide anion production and human platelet adhesion, were
tested. This medicine did not affect either of these cellular
functions, suggesting that its anti-inflammatory effects are
Table 2. Summary of laboratory studies on lymphocytes
 Phytolacca (5c, 7c and 15c) have no mitogenic effect on resting
lymphocytes but on lymphocytes stimulated with ponderal doses of
phytohemagglutinin they inhibit mitosis (36,37).
 Naphthoquinones (plumbagin, alkannin and others) and cytostatic agents
(vincristine, methotrexate and fluorouracil) inhibit lymphoblastic
transformation at relatively low dilutions, whereas higher dilutions
have a stimulatory effect (38).
 High dilutions of Bee venom (Apis) or Phosphorus inhibit blood
lymphocytes (stimulated in vitro with PHA) from healthy subjects while
the cells from immunodepressed patients do not show any significant
inhibition (40).
 A homeopatic complex formulation containing Vincetoxicum 6· to 30·
and Sulfur 4· to 10· stimulate cytokine production by human
lymphocytes (51).
 The homeopathic immunostimulant complex Canova has no genetoxic
properties on human lymphocytes (53).
 Traumeel S inhibits IL-beta, TNF-alpha, and IL-8 production by human
T cells, monocytes and gut epithelial cells (54).
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not due to granulocyte and platelet inhibition. These findings
also suggest that the antimicrobial functions of immune cells
such as granulocytes are not disrupted by Traumeel S.
Human blood neutrophilic granulocytes (neutrophils)
treated with low dilutions (4·) of a homeopathic drug extract
(Podophyllum peltatum) had specific stimulating effects on
their metabolic responses: an enhanced oxidative response to
a subsequent challenge with bacterial formyl-peptides (63)
(Fig. 6). This priming effect was related to superoxide anion
(O2
) release (respiratory burst) and was quantitatively similar
to the priming of the effect of TNF-a. The phenomenon was
observed with a homoeopathic preparation containing, among
other things, podophyllum extract (Podophyllum compositum)
and a 4· homeopathic dilution of Podophyllum (the final
concentration of the active principle was about 0.025 mg/ml),
whereas no enhancement of O2
 release was caused by homoe-
opathic Podophyllum 12· or the other components contained
in the complex homoeopathic preparation. Purified podophyl-
lotoxin caused the same effect at doses of 0.1–10 mg/ml,
whereas doses of more than 100 mg/ml inhibited the respiratory
burst so that pure toxin showed a typical bi-phasic dose–
response curve.
Similar effects were obtained with purified colchicine
(11000 mg/ml), a microtubule-disrupting agent. No priming
by any Podophyllum-derived compound was observed on
neutrophils stimulated with 50 ng/ml phorbol ester (PMA).
Furthermore, both homeopathic podophyllum-derived com-
pounds and pure podophyllotoxin inhibited cell adhesion to
the serum-coated surface of culture microplates. These results
show that low dilutions of a homeopathic drug extract have
stimulant-specific effects on the activation of neutrophil
metabolism. Interest in this drug also comes from the fact
that much higher doses of podophyllotoxin are used by con-
ventional pharmacology to inhibit cell proliferation and these
doses appear to be efficacious against condilomata of the
skin. Priming doses are those contained in the homeopathic
preparation; toxic doses are those contained in the allopathic
preparation.
Electromagnetic Regulation
A paper dealing with regulation of neutrophil metabolism,
published by the group of Benveniste (64), contains apparently
‘incredible’ data that, if confirmed, may have relevance for
the interpretation of homeopathic phenomena. The authors
claimed to have electronically transferred the information of
a potent leukocyte activator (PMA: 4-phorbol-12-beta-
myristate-13-acetate, the active ingredient of croton oil) to a
cell suspension contained in a test tube placed in contact
with a solenoid crossed by an electrical current. In brief, a sus-
pension of neutrophils was positioned at a temperature of 37C
inside a solenoid connected to an oscillator that was also con-
nected to another solenoid containing a solution of PMA. The
oscillator was operated for 15 min, after which neutrophil
activation was recorded by measuring the release of radical
species for a further 45 min. Cell activation occurred only
when the oscillator was operating and not when it was
switched off. As a control, no cell activation occurred when,
instead of PMA, the other solenoid contained its inactive
analogue 4-alpha-phorbol 12,13-didecanoate. The authors
interpreted this by hypothesizing that PMA emits a specific
signal that can be electronically transmitted to neutrophils
without any chemical contact. It is clear that if these results
are confirmed they would strongly support the existence of
‘meta-molecular’ modulations in living systems and open up
an extremely fascinating field of research.
In studies not related to homeopathy, it has been shown that
the adenosine receptors of neutrophils (65), and a number of
biochemical functions (66) are sensitive to externally applied
periodically pulsed weak magnetic fields, in the case of
neutrophil metabolism when the pulses are matched in fre-
quency to the metabolic oscillations. These observations and
the subtle entanglement among different systems such as
homeopathy and acupuncture (67) suggest that high dilutions
of biologically active substances may affect, also through bio-
physical pathways, the signaling and transcriptional levels of
cellular homeostasis.
The main results on granulocytes are summarized in Table 3.
Table 3. Summary of laboratory studies on granulocytes
 Belladonna, Hepar Sulphur, Pyrogenium, Silicea stimulate or inhibit the
leukocyte chemotaxis, with variable effects in different individuals (55).
 Belladonna and Ferrum Phosphoricum 5c and 9c (not Apis 9c) inhibit
zymosan-stimulated metabolism, with individual sensitivity (55).
 Bryonia 4c and 9c stimulate the oxidative metabolism of granulocytes (57).
Manganum phosphoricum (6· to 8·), Magnesium phosphoricum, (6· to 8·)
and Phosphorus (30· to 200·) inhibit the oxidative metabolism of
granulocytes (60). The high-dilution effects of Phosphorus are not evident in
all experiments.
 No effects of Traumeel S on the oxidative metabolism of human
granulocytes (61).
 Podophyllum (4·) and low dilutions of podophyllotoxin prime the oxidative
metabolism of granulocytes; higher doses of the same toxin exert an inhib-
itory effect (63).
 Phorbol myristate acetate, a known activator of granulocytes, seems to act
on these cells also through ‘electronic transmission’ of the signal (64).
Figure 6. Dual effects of Podophyllum and podophyllotoxin on the human
neutrophil metabolism according to the dose (63). For explanation see text.
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Fibroblasts, Osteoblasts and Other
Enzyme Studies
Some in vitro tests have used a model of cytotoxicity in order
to investigate whether homeopathic dilutions of toxic sub-
stances (mainly those having cytotoxic properties when used
at high doses) may have protective effects on cell cultures
of connective tissue cells involved in reparation processes.
Boiron’s group (68) reported that minimal doses (5c) of
mercuric chloride (HgCl2) protect fibroblast cultures from
intoxication by high doses of mercury. The parameter studied
was the mitotic index. This model is obviously based on the
hypothesis of the inverse or paradoxical effects of dose vari-
ations. Others (69) have observed a cytotoxic effect of
HgCl2 on cultured mouse lymphocytes at doses ranging from
105 to 107 M, whereas a growth inhibiting effect without
cytotoxicity was observed at doses ranging from 1016 to
1017 M. However, this effect was not found by another group
studying the action of dilutions ranging from 1010 to 1018 M
using the same model (70).
More recently, it has been reported that osteogenesis in vitro
in rat tibia-derived osteoblasts is promoted by a homeopathic
preparation (FMS-Calciumfluor) containing ultra-low doses
of calcium fluoride associated with calcium monophosphate
(71,72). Alkaline phosphatase, an indicator of osteoblast
maturation, and the incorporation of radiolabelled Ca into the
matrix were increased as compared with untreated control
cultures. The effects of the homeopathic drug were concentra-
tion dependent and specific for its modalities of preparation
and were observed at a concentration about three orders of
magnitude lower than similar effects reported in the literature
by treatment of osteoblast cultures in vitro with NaF.
In order to elucidate potential action mechanisms of an
anti-inflammatory homeopathic complex (Zeel comp. N) and
of its constituents, inhibition of synthesis of leukotriene B4
and prostaglandin by 5-lipoxygenase (5-LOX) and cyclo-
oxygenase 1 and 2 (COX 1 and 2), respectively, were
examined in vitro (73). A reconstituted Zeel comp. N combina-
tion as well as its constituent mother tinctures of Arnica
montana, Sanguinaria canadensis and Rhus toxicodendron
(Toxicodendron quercifolium) showed distinct inhibitory
effects on the 5-LOX and on the COX 1 and COX 2 enzymes.
The effects were observed using low doses of these com-
pounds, in the range of micrograms of original mother tincture.
Discussion
Laboratory studies of cells and especially of leukocytes repres-
ent a fertile field in which homeopathic and conventional
researchers have worked together. The well-established meth-
ods used in modern immunology and cell biology have
been adopted for testing the in vitro effects of commercially
available homeopathic drugs or of active principles diluted
according to the traditional homeopathic methods. Moreover,
the similar principle has been exploited also in reductionistic
models based on different responses of inflammatory cells on
changing the experimental conditions.
The data are still scanty and consider several different
experimental models. So, we could not apply quantitative
methods of evaluation that have been developed by modern
epidemiology for conventional drugs. Since the whole field
has been undergoing difficulties related to its lack of accept-
ance by the academy, as shown in the case of Benveniste
(18,74), the quality of data is still too preliminary, rendering
statistical analysis of papers impossible.
As in clinical research, it is highly conceivable that a pub-
lication bias in favor of papers reporting positive findings do
exist also in basic research and the existence of this bias should
be taken into account to formulate a global judgment about the
field. Due to lack of consensus or criteria of quality in this type
of (admittedly quite preliminary) research, we found it practic-
ally impossible to assign a score of quality to each referenced
paper. As a matter of fact, the studies here described mirror
the relative paucity of scientific homeopathic production con-
cerning action on cells of the immune system.
The Uncertain ‘State-of-the-Art’
The most consistent model in the field of high dilutions is that
of basophil regulation by anti-IgE, histamine and homeopathic
dilutions (75). However, also in this case there is no inter-
national agreement on the validity of the model as a demon-
stration of the ‘high-dilution effect’ or ‘dynamization
phenomenon’. The experiments have not been published in
high-impact journals and have found difficulties in replication
even in the same multicenter trials (24), and, these findings are
not known to the majority of medical scientists. Lack of repro-
ducibility in different laboratories, small differences with the
placebo and, possibly, prejudices have limited acceptance of
these apparently paradoxical results, which would otherwise
make a breakthrough in the field.
Notwithstanding these experimental advancements, the data
in favor of the high-dilution effect in immunological models
are not so consistent and reproducible as it should be for a gen-
eral acceptance by the scientific community. The present state
of physico-chemical knowledge does not allow definite con-
clusions in favor or against the existence of specific physical
states of highly diluted homeopathic remedy. Skeptics are
not convinced by the available evidence. On the other hand,
assuming that the phenomena described in many ‘high-
dilution’ experiments are not laboratory artifacts and that
they do really exist, their difficult reproducibility could be con-
ceivably attributed to the sensitive methods used, which are
unavoidably affected by minimal technical differences and
conditions, including skill of the operator, type of blood
donors, season and day of the experiment, perhaps atmospheric
pressure, the electromagnetic ‘pollution’ of the laboratory,
trace contaminants of the water solutions used to make dilu-
tions, stirring or succussing procedure, time left between a
dilution and subsequent one, the material of which test tubes
are made and similar factors. More extensive and systematic
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research would be necessary in order to discriminate between
these possible sources of laboratory artifacts or of discrepancy
between laboratories.
Methodological Issues
The mast cell/basophil degranulation studies should be
focused on more actively by other laboratories, because this
appears to be the most sensitive model, and if many other
replication studies are carried out we could more easily dis-
cover possible artifacts and/or mechanisms of action. At
this stage of research, pooling and meta-analysis could be
performed only if the database in scarcely investigated areas
(e.g. research in lymphocyte biology, neutrophil metabolism)
is increased and implemented with more consistent results.
A specific methodological issue that should be better invest-
igated considers methods of dilution and of succussion
(dynamization). These methods are well known and are
described in the homeopathic pharmacopoeias, but in the sci-
entific literature high-dilution effects of non-homeopathic sub-
stances often are not reported with suitable detail to allow easy
replication.
The discussion regarding reproducibility in homeopathic
research is a hot topic also in clinical studies, where elusive
phenomena, such as a ‘weak quantum entanglement’, possibly
occurring in the triad composed by doctor–drug–patient, have
been suggested (76–78): the remedy would act in the context
of a tripartite relationship with the patient and the practitioner.
What may be the physical basis of such an entanglement (cor-
relation by quantum entanglement is known and accepted only
in submicroscopic world) is still a matter of speculation. In any
case, assuming that a type of correlation between the tester
intentionality and the drug effect could also take place in the
laboratory system, this would affect the experimental reprodu-
cibility by introducing a further and difficult to control vari-
able. We may expect a contribution of scientific complexity
that can give conceptual tools and methods of analysis of these
kind of interactions (79). Because till now efforts seem to have
concentrated more on homeopathic medicine as an entity in
itself, others also considered the effect of the medicine on the
body or on its subcomponents.
The Sense of Subtle Regulations
The fact that the laboratory-revealed actions are often small
should not be viewed as reducing the significance of findings
because what counts in homeopathy is that a remedy is capable
of ‘regulating’ or ‘triggering’ the body’s response when it is on
a far-from equilibrium state, and not that it acts as directly or
dramatically as a chemical enzyme inhibitor. When the body
is particularly sensitive, characterized by a high degree of
instability and in the proximity of ‘bifurcation points’ of its
evolution, even a small influence could orient the entire
homeodynamic system involved in the disease and thus
become a determinant factor in the final result of the
reaction. Complex systems typically include subsystems that
amplify the small perturbations and chaotic dynamics known
to require fine and repeated impulses rather than drastic
changes. Such considerations are particularly true in the case
of inflammation and the immune system, in which the same
mechanisms can be used for defensive or offensive purposes
(i.e. cure or self-destruction) depending on their site and the
timing and entity of the reaction. This ‘double-faced’ nature
of the phenomena makes them susceptible to fine regulation.
Limitations and Prospects
It is worth admitting that one considerable limitation of in vitro
studies is their highly sectorial nature insofar as they investig-
ate a local phenomenon in standardized conditions, rather than
a complex systemic manifestation such as disease. A number
of in vitro effects of homeopathic medicines provided
examples of U-shaped dose–response curves, which may be
seen as special applications of the principle of similia at the
biological and pathophysiological level, but it is important to
say that this kind of inverse effect is not ‘the’ explanation of
homeopathic effects, which may have further and more com-
plex implications on the level of the organism as a whole.
The demonstration that a given medicine stimulates or inhibits
activity of a blood cell is interesting in itself, but it does not
allow extrapolation (in homeopathy or allopathy) of an action
of the same medicine in humans.
In conclusion, the importance of laboratory studies lies in the
fact that they have made it possible to obtain some preliminary
evidence of the effects of high dilutions/dynamisations under
conditions that exclude any possible effect of suggestion. Fur-
thermore, the data reviewed may give indications of some bio-
chemical and molecular targets of homeopathic agents. There
are many other reasons that make this type of research worth
pursuing. In the future, if reliable and reproducible models
for analyzing the effects of homeopathic dilutions are estab-
lished, it will be possible to deepen our knowledge of the bio-
logical and physical bases of the phenomenon, evaluate the
drug stability over time, identify any causes of decay, and
standardize preparations by comparing activity of different
sources and dilutions of raw materials.
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